Related Experiment Video

Updated: Jul 12, 2025

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

262

[Management of cardiovascular diseases in patients with diabetes : ESC guidelines 2023]

Nikolaus Marx1, Dirk Müller-Wieland2, Marlo Verket2

  • 1Medizinische Klinik I - Kardiologie, Angiologie und Internistische Intensivmedizin, Uniklinik RWTH Aachen, Pauwelsstr. 30, 52074, Aachen, Deutschland. nmarx@ukaachen.de.

Herz
|October 25, 2023
PubMed

Insights

Patients with diabetes mellitus face higher cardiovascular disease risks. New 2023 European Society of Cardiology guidelines offer evidence-based strategies for managing these complex comorbidities and reducing patient cardiovascular risk.

Area of Science:

  • Cardiology
  • Diabetology
  • Internal Medicine

Context:

  • Diabetes mellitus significantly elevates cardiovascular disease (CVD) risk.
  • Managing comorbid diabetes and CVD is crucial for patient prognosis and treatment.
  • Evidence-based strategies are essential for effective cardiovascular risk reduction.

Purpose:

  • To summarize the most relevant aspects of the 2023 European Society of Cardiology (ESC) guidelines.
  • To provide clear recommendations for managing cardiovascular diseases in patients with diabetes.
  • To offer an overview of updated treatment strategies for this patient population.

Summary:

  • The 2023 ESC guidelines address the heightened CVD risk in diabetic patients.
  • Key recommendations focus on integrated management of diabetes and cardiovascular conditions.
  • The guidelines emphasize a proactive approach to cardiovascular risk reduction.

Impact:

  • Improved patient outcomes through optimized, guideline-directed care.
  • Enhanced clinical decision-making for healthcare providers treating diabetic patients with CVD.
  • Facilitation of evidence-based treatment implementation for better cardiovascular risk management.

Keywords:
Chronic renal insufficiencyDiabetes mellitusEvidence-based treatmentHeart disease risk factorsHeart failure

More Related Videos

Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.9K
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

25.8K

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
290
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
9
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
23